DNA topoisomerase I and II in cancer chemotherapy: update and perspectives View Full Text


Ontology type: schema:ScholarlyArticle     

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00685611

DOI

http://dx.doi.org/10.1007/bf00685611

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1032589750

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8387398


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Binding Sites", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Camptothecin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Differentiation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Repair", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Screening Assays, Antitumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Topoisomerase I Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Topoisomerase II Inhibitors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Laboratory of Molecular Pharmacology, Division of Cancer Treatment, National Cancer Institute, BLDG 37, RM 5C27, National Institutes of Health, 20 892, Bethesda, MD, USA", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Laboratory of Molecular Pharmacology, Division of Cancer Treatment, National Cancer Institute, BLDG 37, RM 5C27, National Institutes of Health, 20 892, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pommier", 
        "givenName": "Yves", 
        "id": "sg:person.01357705235.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357705235.00"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/326414a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050852033", 
          "https://doi.org/10.1038/326414a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01966994", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006243515", 
          "https://doi.org/10.1007/bf01966994"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00280363", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019658978", 
          "https://doi.org/10.1007/bf00280363"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1993-03", 
    "datePublishedReg": "1993-03-01", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf00685611", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "32"
      }
    ], 
    "keywords": [
      "cancer chemotherapy", 
      "DNA topoisomerase I", 
      "topoisomerase I", 
      "chemotherapy", 
      "perspective"
    ], 
    "name": "DNA topoisomerase I and II in cancer chemotherapy: update and perspectives", 
    "pagination": "103-108", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1032589750"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00685611"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8387398"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00685611", 
      "https://app.dimensions.ai/details/publication/pub.1032589750"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T16:51", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_244.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf00685611"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00685611'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00685611'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00685611'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00685611'


 

This table displays all metadata directly associated to this object as RDF triples.

125 TRIPLES      20 PREDICATES      45 URIs      34 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00685611 schema:about N1b3733d304784bc5b23527e7690c299f
2 N2014ffdda7184de5acbfd170d861f1ba
3 N3930a36f53cd40538eb54c59511fd3a5
4 N3d3f852fa97a49de904da708644f0d14
5 N42f5021a8625440591578f9050595124
6 N49256eee054f440bbcc5a8cc6f5ae24f
7 N8555e2af76f2410db0dda09b3075fd84
8 N92eb8f3ef0e84c22b211da16e865425c
9 Nb709dbcab0c8472d93f9e9f6648d7c3d
10 Nc67d166689ff4e4788983a942ef712bc
11 Ne81ff5edcae0419598d75d8436396fa3
12 Nea393870c393477a9facecc943006857
13 anzsrc-for:11
14 anzsrc-for:1115
15 schema:author N7e1bb22a932e4af0b69341666b9d6b58
16 schema:citation sg:pub.10.1007/bf00280363
17 sg:pub.10.1007/bf01966994
18 sg:pub.10.1038/326414a0
19 schema:datePublished 1993-03
20 schema:datePublishedReg 1993-03-01
21 schema:genre article
22 schema:isAccessibleForFree false
23 schema:isPartOf N16ba8544dd6848ebbc09a6a776cee096
24 N54b5d5fe77304f9e9f93c87252aadfd2
25 sg:journal.1088364
26 schema:keywords DNA topoisomerase I
27 cancer chemotherapy
28 chemotherapy
29 perspective
30 topoisomerase I
31 schema:name DNA topoisomerase I and II in cancer chemotherapy: update and perspectives
32 schema:pagination 103-108
33 schema:productId N0fb9b7fa23b4461c98f977f8b0545c66
34 N5aa7c67ed60349868631cf267ac2ef54
35 Nb900b96f1041462f9fbf69ba3ebf1031
36 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032589750
37 https://doi.org/10.1007/bf00685611
38 schema:sdDatePublished 2022-08-04T16:51
39 schema:sdLicense https://scigraph.springernature.com/explorer/license/
40 schema:sdPublisher N6cd130e096a44404b53850268fc492f3
41 schema:url https://doi.org/10.1007/bf00685611
42 sgo:license sg:explorer/license/
43 sgo:sdDataset articles
44 rdf:type schema:ScholarlyArticle
45 N0fb9b7fa23b4461c98f977f8b0545c66 schema:name dimensions_id
46 schema:value pub.1032589750
47 rdf:type schema:PropertyValue
48 N16ba8544dd6848ebbc09a6a776cee096 schema:volumeNumber 32
49 rdf:type schema:PublicationVolume
50 N1b3733d304784bc5b23527e7690c299f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
51 schema:name Drug Resistance
52 rdf:type schema:DefinedTerm
53 N2014ffdda7184de5acbfd170d861f1ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
54 schema:name DNA Repair
55 rdf:type schema:DefinedTerm
56 N3930a36f53cd40538eb54c59511fd3a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
57 schema:name Drug Screening Assays, Antitumor
58 rdf:type schema:DefinedTerm
59 N3d3f852fa97a49de904da708644f0d14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
60 schema:name Topoisomerase I Inhibitors
61 rdf:type schema:DefinedTerm
62 N42f5021a8625440591578f9050595124 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Cell Differentiation
64 rdf:type schema:DefinedTerm
65 N49256eee054f440bbcc5a8cc6f5ae24f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Camptothecin
67 rdf:type schema:DefinedTerm
68 N54b5d5fe77304f9e9f93c87252aadfd2 schema:issueNumber 2
69 rdf:type schema:PublicationIssue
70 N5aa7c67ed60349868631cf267ac2ef54 schema:name doi
71 schema:value 10.1007/bf00685611
72 rdf:type schema:PropertyValue
73 N6cd130e096a44404b53850268fc492f3 schema:name Springer Nature - SN SciGraph project
74 rdf:type schema:Organization
75 N7e1bb22a932e4af0b69341666b9d6b58 rdf:first sg:person.01357705235.00
76 rdf:rest rdf:nil
77 N8555e2af76f2410db0dda09b3075fd84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Neoplasms
79 rdf:type schema:DefinedTerm
80 N92eb8f3ef0e84c22b211da16e865425c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Topoisomerase II Inhibitors
82 rdf:type schema:DefinedTerm
83 Nb709dbcab0c8472d93f9e9f6648d7c3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Humans
85 rdf:type schema:DefinedTerm
86 Nb900b96f1041462f9fbf69ba3ebf1031 schema:name pubmed_id
87 schema:value 8387398
88 rdf:type schema:PropertyValue
89 Nc67d166689ff4e4788983a942ef712bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Antineoplastic Agents
91 rdf:type schema:DefinedTerm
92 Ne81ff5edcae0419598d75d8436396fa3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Drug Design
94 rdf:type schema:DefinedTerm
95 Nea393870c393477a9facecc943006857 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Binding Sites
97 rdf:type schema:DefinedTerm
98 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
99 schema:name Medical and Health Sciences
100 rdf:type schema:DefinedTerm
101 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
102 schema:name Pharmacology and Pharmaceutical Sciences
103 rdf:type schema:DefinedTerm
104 sg:journal.1088364 schema:issn 0344-5704
105 1432-0843
106 schema:name Cancer Chemotherapy and Pharmacology
107 schema:publisher Springer Nature
108 rdf:type schema:Periodical
109 sg:person.01357705235.00 schema:affiliation grid-institutes:grid.48336.3a
110 schema:familyName Pommier
111 schema:givenName Yves
112 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357705235.00
113 rdf:type schema:Person
114 sg:pub.10.1007/bf00280363 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019658978
115 https://doi.org/10.1007/bf00280363
116 rdf:type schema:CreativeWork
117 sg:pub.10.1007/bf01966994 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006243515
118 https://doi.org/10.1007/bf01966994
119 rdf:type schema:CreativeWork
120 sg:pub.10.1038/326414a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050852033
121 https://doi.org/10.1038/326414a0
122 rdf:type schema:CreativeWork
123 grid-institutes:grid.48336.3a schema:alternateName Laboratory of Molecular Pharmacology, Division of Cancer Treatment, National Cancer Institute, BLDG 37, RM 5C27, National Institutes of Health, 20 892, Bethesda, MD, USA
124 schema:name Laboratory of Molecular Pharmacology, Division of Cancer Treatment, National Cancer Institute, BLDG 37, RM 5C27, National Institutes of Health, 20 892, Bethesda, MD, USA
125 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...